AlphaTON Capital Corp.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ATON research report →
Companywww.portagebiotech.com
AlphaTON Capital Corp. is the rebranded entity formerly known as Portage Biotech Inc. , a clinical-stage immuno-oncology company transitioning into a digital asset treasury model focused on accumulating and staking Toncoin (TON).
- CEO
- Brittany Kaiser
- IPO
- 2002
- Employees
- 4
- HQ
- Road Town, US
Price Chart
Valuation
- Market Cap
- $794.90K
- P/E
- -0.04
- P/S
- 0.00
- P/B
- 0.09
- EV/EBITDA
- -0.49
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -925.11%
- ROIC
- -116.31%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $-6,767,000 · 91.02%
- EPS
- $-5.72 · -54.59%
- Op Income
- $-7,418,000
- FCF YoY
- 61.80%
Performance & Tape
- 52W High
- $13.80
- 52W Low
- $0.18
- 50D MA
- $0.36
- 200D MA
- $3.14
- Beta
- 0.49
- Avg Volume
- 8.60M
Get TickerSpark's AI analysis on ATON
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our ATON Coverage
We haven't published any research on ATON yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate ATON Report →